Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Myopathy breakthrough paves way for new treatments
Dr Charlotte Maile and Professor Richard Piercy.

RVC study reveals mechanisms that underlie form of 'tying-up'

New research has revealed the molecular mechanisms that underlie a common form of ‘tying-up’ in horses.

Tying-up, scientifically known as Type 1 Polysaccharide Storage Myopathy (PSSM1), is a common condition that damages equine muscle tissue.  

Animals affected by the condition have a mutation of a key enzyme (glycogen synthase) which is involved in energy metabolism in muscle.

They also suffer from a build-up of polysaccharide (a form of carbohydrate) and increased storage of glycogen. Horses that carry the condition are prone to ‘tying up and muscle weakness.

Until now, nobody knew the precise mechanism by which the mutation caused increased enzyme activity in muscles. But new research, published in the journal Biochim Biohys Acta, shows that the mutation leads to a change in the enzyme’s structure, leaving it permanently active.

This hyperactivity, the team explains, accounts for the increased muscle glycogen and the accumulation of polysaccharide.

Led by
Dr Charlotte Maile and Professor Richard Piercy of the RVC, the research was conducted by an international team of scientists from the University of Copenhagen, University of Minnesota, Indiana University School of Medicine and Liverpool John Moore’s University.

It is hoped that the breakthrough will enable the team to work towards improving treatments and management for this disorder, to improve the welfare of affected horses.

"PSSM1 is a very common disease, especially in some breeds. Finally we know the reason why these horses store excessive glycogen and polysaccharide in their muscles. Our goal now is to use this information in designing new treatments and management strategies,” said Professor Richard Piercy, Professor of Comparative Neuromuscular Disease.

Prof Richard Piercy added: “Managing horses that tie-up is hard, and some recommended treatments work poorly in some animals. By revealing the precise mechanism for this form of tying up, our work should make a real difference.

“Our hope is that by targeting specific approaches to the problem, rather than a ‘one treatment fits all’ - horse welfare will be improved allowing them to get back to exercise, which has to be good for the horse and their owner”.

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Milk recalled over presence of veterinary medicines

Graham's Family Dairy has issued a recall for its semi-skimmed milk due to the presence of veterinary medicines in the product.

In a risk statement, the Food Standards Agency said the presence of the medicines, including penicillin, make the milk unsafe to consume and 'may be a possible health risk for anyone with an allergy to antibiotics'.

Customers who bought the product are advised to return it to the store of purchase for a full refund.